Final efficacy outcomes of atezolizumab with chemoradiation for unresectable NSCLC: The phase II DETERRED trial
Yufei Liu, Luyang Yao, Neda Kalhor, Brett W. Carter, Mehmet Altan, George R. Blumenschein, Lauren A. Byers, Frank V. Fossella, Don L. Gibbons, Jonathan M. Kurie, Charles Lu, Ferdinandos Skoulidis, Joe Y. Chang, Zhongxing Liao, Daniel R. Gomez, Michael S. O’Reilly, John V. Heymach, Anne S. Tsao, Steven H. Lin
Topics & Concepts
AtezolizumabMedicineOncologyInternal medicinePhases of clinical researchIntensive care medicineClinical trialCancerPembrolizumabImmunotherapyCancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment